Source generic, branded and specialty medicines from India with support built around the way international buyers actually procure: product availability, quantity, destination, documentation and delivery requirements. The service is designed for importers, distributors, hospitals, NGOs, government procurement teams and other authorized healthcare organizations.
India-level export context; these figures describe India’s pharmaceutical exports, not IGM-specific sales.
India pharmaceutical export trend
India’s pharma exports have grown steadily
India’s drug and pharmaceutical exports rose from about US$24.44 billion in FY2020–21 to US$30.47 billion in FY2024–25. The figures below are India-level trade data, not Indian Generic Medicines sales.
$24.44B
FY21
$24.59B
FY22
$25.39B
FY23
$27.84B
FY24
$30.47B
FY25
Source: Pharmexcil trade statistics and annual/export reports. FY2024–25 exports were US$30.46–30.47B, with 9.4% year-on-year growth. citeturn756711search1turn756711search25turn756711search26
Why source generic medicines from India?
Why international buyers source medicines from India
India has built a large pharmaceutical manufacturing and export base, with medicines reaching more than 200 markets. In FY2024–25, India’s pharmaceutical exports reached about US$30.47 billion; North America and Europe together accounted for roughly half of export value. For an individual buyer, the practical questions are product availability, destination requirements, documentation, price, quantity and delivery.
What Indian Generic Medicines helps buyers coordinate
Indian Generic Medicines helps turn an international medicine requirement into a workable sourcing request. Buyers can share the molecule, strength, dosage form, quantity and destination so the team can review available supply channels and the documentation relevant to the order.
Depending on the requirement, the discussion may cover supplier availability, commercial quantities, export documents, shipping conditions, lead time and destination-side requirements.
Who this page is for
Who can source through this export service
The sourcing conversation changes depending on who is buying, why the medicine is needed and where it will be supplied. These routes help visitors find the right next step quickly.
Importers & Distributors
Product availability, commercial quantities, documentation and recurring supply discussions for licensed import channels.
Hospitals & Clinical Institutions
Institutional requirements for specialty, oncology, injectable and other medicines, with procurement and regulatory considerations discussed early.
NGOs & Humanitarian Programs
Procurement discussions for healthcare programmes, tenders and humanitarian supply where the programme and destination rules allow.
Government & Institutional Buyers
Bulk medicine requirements, tender-oriented sourcing and documentation coordination for eligible public-sector procurement.
Wholesale Buyers
Commercial procurement for authorized wholesale, distribution and recurring supply programmes.
Pharmacies & Healthcare Networks
Sourcing discussions for licensed pharmacy and healthcare networks, subject to local registration and distribution requirements.
Research & Specialty Requirements
Specialty and difficult-to-source requirements can be reviewed where a lawful supply route exists.
Individual Patient Enquiries
Individual patient requests are handled differently from commercial export orders and may require a regulated named-patient or other special-access pathway where permitted.
Global pharmaceutical markets
Where India’s pharmaceutical exports reach
India’s pharmaceutical exports span North America, Europe, Africa, the Middle East, Asia, CIS, Latin America & the Caribbean and Oceania. Our country pages provide a starting point for market-specific sourcing conversations; the exact rules still depend on the product and destination.
Africa
Country-focused sourcing conversations for importers, distributors, hospitals and institutional buyers.
This hub is designed to connect visitors to the relevant medicine or therapeutic page rather than forcing every product keyword into one export page.
Oncology & Specialty Medicines
Oncology and specialty medicine requirements, including oral and injectable products where available.
Anti-Infectives & Antibiotics
Anti-infective and antimicrobial medicine sourcing for authorized international procurement.
Cardiovascular & Diabetes
Cardiovascular and metabolic medicines used in recurring chronic-care procurement.
Neurology & Psychiatry
Neurology and psychiatry medicine sourcing for suitable international requirements.
Gastroenterology
Gastroenterology categories across relevant dosage forms and product specifications.
Respiratory & Allergy
Respiratory and allergy medicine sourcing for eligible international buyers.
Dermatology
Dermatology product categories subject to availability and destination-market requirements.
Injectables & Biologics
Biologics and temperature-sensitive products may require controlled storage, packaging and cold-chain handling.
Export documentation
The documents international medicine buyers should discuss early
The document set is product- and market-specific. The following are common discussion points rather than a universal checklist.
Area
Typical discussion point
Why it matters
Product identity
Generic name, strength, dosage form, pack size
Confirms the exact medicine and commercial specification.
Quality documents
COA, batch information, manufacturer documents where applicable
Supports product and batch verification.
Origin & export
Country-of-origin and export documentation as required
Supports customs and destination-side procurement.
Regulatory
Registration, import permit or local authorization where applicable
Medicine supply is market-specific and may require prior authorization.
Logistics
Storage, temperature, freight and delivery requirements
Important for sensitive and time-critical medicines.
Commercial
MOQ, quotation, lead time, payment and contract terms
Aligns supply with the buyer’s procurement plan.
Pharmaceutical logistics
Logistics that protect medicine quality from dispatch to delivery
Exporting medicines is not only about freight. Storage conditions, packaging, transit time, temperature exposure and documentation can affect whether a shipment reaches the destination in the condition expected.
Shipment Planning
Freight mode, dispatch timing, route planning and destination handling are considered around the product and order.
Temperature Control
Temperature-sensitive products may require validated packaging, controlled storage and cold-chain transportation.
Shipment Documentation
Commercial and product documents are coordinated so the shipment can be checked at export and import stages.
Lead-Time Management
Estimated lead time is discussed early, especially where products require controlled handling or destination approvals.
Destination Coordination
Importer, customs and local handling requirements are considered before dispatch where information is available.
Global Delivery Support
International delivery communication continues through the shipment stage so buyers know the next milestone.
Cold-chain note:
For temperature-sensitive medicines, the required temperature range, packaging, storage and transport method must be matched to the specific product. Not every medicine requires cold-chain handling.
Export workflow
How an international medicine enquiry is handled
01
Requirement
Share the molecule or product name, strength, dosage form, quantity and destination.
02
Sourcing
The team reviews availability and suitable sourcing channels for the requirement.
03
Documentation
Required product, quality and export documents are discussed for the order.
04
Logistics
Shipping method, storage, temperature and freight requirements are coordinated.
05
Delivery
Dispatch information and delivery communication continue through the shipment stage.
For B2B buyers: what to include in your enquiry
Medicine name or active ingredient
Strength, dosage form and pack requirement
Estimated order quantity or annual requirement
Destination country and delivery location
Importer, distributor or institutional status
Registration or import-permit status, if known
Required delivery timeline
For patients and caregivers
If your search is about a medicine that is difficult to obtain locally, the correct route may be different from a commercial export order. Availability and lawful supply can depend on prescription status, local authorization and destination-country rules.
IGM can review patient-specific requirements through applicable patient-access or named-patient pathways where legally permissible and properly documented.
What to compare when evaluating generic medicine exporting Indian companies
The phrase generic medicine exporting Indian companies covers a broad market. Buyers should compare more than catalogue size: look at the supplier’s product availability, export experience, documentation process, destination-market understanding, logistics capability and ability to communicate clearly about what can and cannot be supplied.
Useful questions to ask before placing an order
Can the supplier confirm the exact strength, dosage form and pack?
Can they explain which documents are available for the product?
Do they understand the destination-market import process?
Can they support temperature-sensitive shipments when required?
Can they provide a clear quotation, lead time and shipment plan?
Can they distinguish manufacturer claims from exporter-level services?
Why this matters for B2B procurement
For distributors, hospitals, NGOs and institutional buyers, a reliable export partner should reduce uncertainty rather than simply add another product catalogue to the procurement process.
IGM’s enquiry workflow is designed to collect the product, quantity and destination information first, then work through sourcing, documentation and delivery requirements.
Why IGM
Choose an export partner for the whole sourcing journey
For international buyers, the useful part of an export partner is coordination: understanding the requirement, checking supply options, aligning documents and keeping the order moving through logistics.
Manufacturer Sourcing
Sourcing across generic, branded and specialty medicine categories, subject to availability.
Export Coordination
Commercial, documentation and shipment discussions handled through one enquiry route.
Market Awareness
Destination-specific questions are identified early because medicine import requirements differ by market.
Long-Term Supply
Support for repeat orders, distributor relationships and longer-term sourcing discussions.
FAQs
Frequently asked questions about exporting generic medicines from India
International supply depends on the product, buyer status, destination and applicable rules. Commercial enquiries are best handled through licensed or authorized importers, distributors and institutions.
India exports pharmaceutical products to more than 200 countries. IGM maintains regional and country-specific export pages, but the exact ability to supply a product depends on destination rules, registration and import requirements.
Hospitals, NGOs, institutional buyers and government procurement teams can submit requirements for review, subject to their procurement process and applicable regulations.
Provide medicine name, strength, dosage form, quantity, destination country, delivery timeline and any known registration or import requirements.
Requirements vary by country and product. Some markets require product registration or prior authorization; others may have specific institutional or special-access routes. Confirm destination requirements with the competent authority or licensed importer.
Temperature-sensitive medicines can require controlled storage, validated packaging and temperature-managed transport. IGM supports coordination of cold-chain logistics where applicable.
Ready to source generic medicines from India?
Send the molecule or product name, strength, quantity and destination. We can review the sourcing route, documentation needs and delivery requirements for your market.
